SPONSOR: Sen. Buckson & Rep. Yearick Sens. Hansen, Hocker, Huxtable, Mantzavinos, Pettyjohn, Seigfried, Sokola; Reps. Gray, Morrison, Ortega, Ross Levin, Vanderwende DELAWARE STATE SENATE 153rd GENERAL ASSEMBLY SENATE CONCURRENT RESOLUTION NO. 34 RECOGNIZING THE MONTH OF APRIL 2025 AS "PARKINSON'S DISEASE AWARENESS MONTH" IN THE STATE OF THE DELAWARE.
SPONSOR: Sen. Buckson & Rep. Yearick Sens. Hansen, Hocker, Huxtable, Mantzavinos, Pettyjohn, Seigfried, Sokola; Reps. Gray, Morrison, Ortega, Ross Levin, Vanderwende
SPONSOR: Sen. Buckson & Rep. Yearick
Sens. Hansen, Hocker, Huxtable, Mantzavinos, Pettyjohn, Seigfried, Sokola; Reps. Gray, Morrison, Ortega, Ross Levin, Vanderwende
SPONSOR:
Sen. Buckson & Rep. Yearick
Sens. Hansen, Hocker, Huxtable, Mantzavinos, Pettyjohn, Seigfried, Sokola; Reps. Gray, Morrison, Ortega, Ross Levin, Vanderwende
DELAWARE STATE SENATE
153rd GENERAL ASSEMBLY
SENATE CONCURRENT RESOLUTION NO. 34
RECOGNIZING THE MONTH OF APRIL 2025 AS "PARKINSON'S DISEASE AWARENESS MONTH" IN THE STATE OF THE DELAWARE.
WHEREAS, Parkinsons disease (PD) is a chronic and progressive disease that affects the nervous system and is the second most common neurodegenerative disease in the United States; and WHEREAS, the symptoms of PD can include tremors, slowed movement, rigid muscles, impaired posture and balance, loss of automatic movements, writing changes, and speech changes; and WHEREAS, according to the Parkinsons Clinic at the University of Delaware, approximately 2,000 Delawareans were diagnosed with PD in 2024; and WHEREAS, there are more than 8.5 million people living with PD worldwide; and WHEREAS, the cost of PD is estimated to be nearly $52 billion each year in the United States and is expected to rise to $80 billion annually by 2037; and WHEREAS, the average cost of medication is $2,500 per person per year, and surgery can cost up to $100,000 per person; and WHEREAS, the Parkinsons Foundation estimates that nearly one million people in the U.S. are living with PD, which is more than the combined number of people diagnosed with multiple sclerosis, muscular dystrophy, and Lou Gehrigs disease (or Amyotrophic Lateral Sclerosis), a figure that is expected to rise to 1.2 million by 2030; and WHEREAS, the cause of PD is unknown and there is no current cure for the disease; and WHEREAS, the Parkinsons Foundation works each April to raise awareness about the disease; and WHEREAS, the Parkinson Foundation has invested more than $425 million in PD research and clinical care since 1957; and WHEREAS, increased public awareness, early diagnosis, expanded research, and accessible care are critical to improving the quality of life for those living with Parkinsons disease and ultimately finding a cure. NOW, THEREFORE: BE IT RESOLVED by the Senate of the 153rd General Assembly of the State of Delaware, the House of Representatives concurring therein, that April 2025 is recognized as Parkinsons Disease Awareness Month in the State of Delaware.
WHEREAS, Parkinsons disease (PD) is a chronic and progressive disease that affects the nervous system and is
the second most common neurodegenerative disease in the United States; and
WHEREAS, the symptoms of PD can include tremors, slowed movement, rigid muscles, impaired posture and balance, loss of automatic movements, writing changes, and speech changes; and
WHEREAS, according to the Parkinsons Clinic at the University of Delaware, approximately 2,000 Delawareans were diagnosed with PD in 2024; and
WHEREAS, there are more than 8.5 million people living with PD worldwide; and
WHEREAS, the cost of PD is estimated to be nearly $52 billion each year in the United States and is expected to rise to $80 billion annually by 2037; and
WHEREAS, the average cost of medication is $2,500 per person per year, and surgery can cost up to $100,000 per person; and
WHEREAS, the Parkinsons Foundation estimates that nearly one million people in the U.S. are living with PD, which is more than the combined number of people diagnosed with multiple sclerosis, muscular dystrophy, and Lou Gehrigs disease (or Amyotrophic Lateral Sclerosis), a figure that is expected to rise to 1.2 million by 2030; and
WHEREAS, the cause of PD is unknown and there is no current cure for the disease; and
WHEREAS, the Parkinsons Foundation works each April to raise awareness about the disease; and
WHEREAS, the Parkinson Foundation has invested more than $425 million in PD research and clinical care since 1957; and
WHEREAS, increased public awareness, early diagnosis, expanded research, and accessible care are critical to improving the quality of life for those living with Parkinsons disease and ultimately finding a cure.
NOW, THEREFORE:
BE IT RESOLVED by the Senate of the 153rd General Assembly of the State of Delaware, the House of Representatives concurring therein, that April 2025 is recognized as Parkinsons Disease Awareness Month in the State of Delaware.
SYNOPSIS This Resolution recognizes April 2025 as "Parkinson's Disease Awareness Month" in the State of Delaware. Author: Senator Buckson
SYNOPSIS
This Resolution recognizes April 2025 as "Parkinson's Disease Awareness Month" in the State of Delaware.
Author: Senator Buckson